Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Australian (ASX) Healthcare Sector Analysis

UpdatedFeb 03, 2026
DataAggregated Company Financials
Companies125
  • 7D-2.2%
  • 3M-4.8%
  • 1Y-28.5%
  • YTD-1.6%

Over the last 7 days, the Healthcare industry has dropped 2.2%, driven by CSL declining 1.4%. Overall the industry is down 28% in 12 months. As for the next few years, earnings are expected to grow by 17% per annum.

Sector Valuation and Performance

Has the Australian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 03 Feb 2026AU$211.8bAU$72.8bAU$4.3b31.7x48.8x2.9x
Thu, 01 Jan 2026AU$213.7bAU$73.9bAU$4.5b32.9x47.4x2.9x
Sat, 29 Nov 2025AU$227.7bAU$74.6bAU$4.6b31.9x49.8x3.1x
Mon, 27 Oct 2025AU$243.8bAU$74.9bAU$4.6b30.6x52.9x3.3x
Wed, 24 Sep 2025AU$239.1bAU$74.5bAU$4.6b31.7x52.5x3.2x
Fri, 22 Aug 2025AU$250.4bAU$71.1bAU$5.3b26.1x47.4x3.5x
Sun, 20 Jul 2025AU$270.7bAU$71.8bAU$4.3b29.5x63.3x3.8x
Tue, 17 Jun 2025AU$256.0bAU$71.7bAU$4.3b25.8x59.9x3.6x
Thu, 15 May 2025AU$252.6bAU$70.3bAU$4.8b27.4x52.2x3.6x
Sat, 12 Apr 2025AU$237.7bAU$71.4bAU$5.0b25.6x47.5x3.3x
Mon, 10 Mar 2025AU$261.1bAU$71.1bAU$4.9b28.9x53.1x3.7x
Wed, 05 Feb 2025AU$245.1bAU$65.5bAU$3.4b26.5x72.3x3.7x
Fri, 03 Jan 2025AU$244.6bAU$68.9bAU$3.4b25.7x72.6x3.5x
Sun, 01 Dec 2024AU$248.2bAU$67.9bAU$3.2b26.8x77.8x3.7x
Tue, 29 Oct 2024AU$242.1bAU$67.6bAU$3.1b26x77x3.6x
Thu, 26 Sep 2024AU$235.0bAU$66.6bAU$3.0b24.7x78.3x3.5x
Sat, 24 Aug 2024AU$244.3bAU$64.4bAU$3.2b36.9x75.5x3.8x
Mon, 22 Jul 2024AU$244.6bAU$62.7bAU$2.6b33.1x93.8x3.9x
Wed, 19 Jun 2024AU$235.6bAU$62.9bAU$2.6b33x89.1x3.7x
Fri, 17 May 2024AU$230.3bAU$61.0bAU$2.6b26.3x88.9x3.8x
Sun, 14 Apr 2024AU$223.9bAU$61.7bAU$2.7b25.8x83.6x3.6x
Tue, 12 Mar 2024AU$222.6bAU$61.4bAU$2.6b25.7x85.2x3.6x
Thu, 08 Feb 2024AU$232.6bAU$59.2bAU$3.0b25.3x76.5x3.9x
Sat, 06 Jan 2024AU$225.1bAU$60.1bAU$2.8b24.5x80.3x3.7x
Mon, 04 Dec 2023AU$206.4bAU$60.1bAU$2.8b24.8x73.1x3.4x
Wed, 01 Nov 2023AU$185.4bAU$61.2bAU$3.0b24.4x62x3x
Fri, 29 Sep 2023AU$200.5bAU$61.2bAU$2.9b24.9x68.6x3.3x
Sun, 27 Aug 2023AU$207.7bAU$61.5bAU$2.9b24.9x71.3x3.4x
Tue, 25 Jul 2023AU$212.2bAU$57.5bAU$2.9b27.4x74.3x3.7x
Thu, 22 Jun 2023AU$221.3bAU$57.4bAU$2.9b26x77.6x3.9x
Sat, 20 May 2023AU$231.6bAU$57.7bAU$2.9b27.7x80.4x4x
Mon, 17 Apr 2023AU$231.5bAU$57.1bAU$2.9b28.5x80.9x4.1x
Wed, 15 Mar 2023AU$215.9bAU$57.1bAU$2.9b24.9x75.4x3.8x
Fri, 10 Feb 2023AU$227.2bAU$55.1bAU$3.9b24.9x57.9x4.1x
Price to Earnings Ratio

57.9x


Total Market Cap: AU$227.2bTotal Earnings: AU$3.9bTotal Revenue: AU$55.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Healthcare Sector Price to Earnings3Y Average 69.8x202420252026
Current Industry PE
  • Investors are pessimistic on the Australian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 48.8x which is lower than its 3-year average PE of 69.8x.
  • The 3-year average PS ratio of 3.6x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 3.4% per year over the last three years.
  • Revenues for these companies have grown 9.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Australian Healthcare sector?

AU Market-1.47%
Healthcare-2.17%
Healthcare Services-0.17%
Biotech-2.09%
Medical Equipment-3.63%
Healthtech-4.18%
Pharma-8.91%
Life Sciences-11.57%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 2kx.
    • Analysts are expecting annual earnings growth of 25.3%, which is lower than the prior year's growth of 62.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 70% over the next 5 years.
  • This is better than its past earnings growth rate of 2.4% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SIG Sigma HealthcareAU$3.141.6%
+AU$575.1m		n/aPE68.2x
REG Regis HealthcareAU$6.863.0%
+AU$60.5m		6.4%PE42.4x
LDX Lumos Diagnostics HoldingsAU$0.2731.7%
+AU$51.5m		800.0%PS12x
IMR Imricor Medical SystemsAU$2.036.8%
+AU$41.7m		52.1%PS604.9x
SPL Starpharma HoldingsAU$0.4220.0%
+AU$29.4m		320.0%PS30.1x

Latest News

MSB
AU$2.49
Mesoblast
7D
-7.4%
1Y
-21.9%
NEU
AU$14.63
Neuren Pharmaceuticals
7D
-16.1%
1Y
11.0%
PME
AU$177.56
Pro Medicus
7D
-6.6%
1Y
-37.5%

Cloud Imaging And AI Risks Will Persist Yet Support Long Term Upside Potential

Catalysts About Pro Medicus Pro Medicus provides enterprise imaging software and radiology information systems, with a focus on cloud based, transaction priced platforms used by large health systems and academic medical centers. What are the underlying business or industry changes driving this perspective?
SHL
AU$22.78
Sonic Healthcare
7D
-1.5%
1Y
-19.2%

SHL: Modest Margin Improvement Will Support Attractive Future Earnings Multiple

Analysts have trimmed their price expectations for Sonic Healthcare, reflecting a slightly lower fair value estimate to A$26.84 from A$27.68, along with updated assumptions for revenue growth, profit margins and future P/E levels. Valuation Changes Fair Value: trimmed from A$27.68 to A$26.84, a small reduction in the estimated fair value per share.
TLX
AU$10.21
Telix Pharmaceuticals
7D
-13.9%
1Y
-65.5%
IMR
AU$2.03
Imricor Medical Systems
7D
6.8%
1Y
52.1%

MRI Guided Cardiac Ablation Adoption Will Transform Long Term Prospects For This Undervalued Player

Catalysts About Imricor Medical Systems Imricor Medical Systems develops MRI compatible cardiac ablation systems intended to enable electrophysiology procedures inside the MRI suite. What are the underlying business or industry changes driving this perspective?
REG
AU$6.86
Regis Healthcare
7D
3.0%
1Y
6.4%
LDX
AU$0.27
Lumos Diagnostics Holdings
7D
31.7%
1Y
800.0%

Lumos Diagnostics Holdings Limited (ASX:LDX) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Jan 27
Lumos Diagnostics Holdings Limited (ASX:LDX) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
CSL
AU$178.11
CSL
7D
-2.3%
1Y
-34.9%

CSL: Share Recovery Will Be Driven By Seqirus Reset And Demerger Deferral

Analysts have raised their fair value target for CSL to A$232.54. This reflects slightly adjusted assumptions for revenue growth, profit margins and future P/E multiples after recent upgrades and renewed interest in the shares.
ALA
AU$0.10
Arovella Therapeutics
7D
17.6%
1Y
-48.7%
SIG
AU$3.14
Sigma Healthcare
7D
1.6%
1Y
n/a

With Sigma Healthcare Limited (ASX:SIG) It Looks Like You'll Get What You Pay For

Jan 17
With Sigma Healthcare Limited (ASX:SIG) It Looks Like You'll Get What You Pay For
RHY
AU$0.19
Rhythm Biosciences
7D
35.7%
1Y
120.9%
COH
AU$266.76
Cochlear
7D
-3.8%
1Y
-14.6%

Investors Shouldn't Overlook Cochlear's (ASX:COH) Impressive Returns On Capital

Jan 11
Investors Shouldn't Overlook Cochlear's (ASX:COH) Impressive Returns On Capital
SLD
AU$1.31
Saluda Medical
7D
9.7%
1Y
n/a
SPL
AU$0.42
Starpharma Holdings
7D
20.0%
1Y
320.0%
CU6
AU$2.96
Clarity Pharmaceuticals
7D
-14.9%
1Y
-16.9%